Founded in 1949, The Leukemia and Lymphoma Society is the world’s largest nonprofit fighting blood cancer. In our 70-year history, we have invested more than $1.2 billion in research leading to breakthroughs in cancer treatment.
Where LLS Invests Your Donations & Fundraised Dollars
The mission of The Leukemia & Lymphoma Society (LLS) is: Cure leukemia, lymphoma, Hodgkin’s disease and myeloma, and improve the quality of life of patients and their families.
There are no means of preventing or early screening for most blood cancers. LLS’s research agenda is focused on finding cures & drives research in areas of unmet medical need, and helps to bridge the gap between academic discovery and drug development. LLS identifies and funds the most promising blood cancer research projects and forges partnerships with academic institutions, biotechnology & pharmaceutical companies to accelerate the development of new therapies.
LLS recognizes that finding cures is not enough; we need to ensure that patients have access to the treatments, services and providers they need to live longer, better, healthier lives. LLS is dedicated to removing barriers to care. By providing our network of advocates a powerful voice, the Policy and Advocacy Team drives policies that accelerate the development and approval of innovative treatments and ensure that patients have sustainable access to quality, affordable coordinated care.
LLS is the leading source of free, highly specialized blood cancer information, education and support for patients, survivors, families and healthcare professionals. We touch patients in their communities through our chapters across the U.S. and Canada. We advocate for blood cancer survivors and their families, helping patients navigate their cancer treatments and ensuring they have access to quality, affordable and coordinated care.
LLS’s advances in research and innovation have led to over 67 new drugs that have been approved by the FDA to fight all cancers. Almost half of those were originally approved to fight blood cancers. Blood is easier to test and re-test than tumors, and researchers turn to studying blood cancers to help most cancer disease states. Cancer costs $895 billion dollars a year – last year, LLS alone invested $49.3 million into 300 projects at the finest institutions around the world.